Search Results
You are looking at 1 - 7 of 7 items for
- Author: R Romero x
- Refine by access: All content x
Search for other papers by R Romero in
Google Scholar
PubMed
Search for other papers by B Casanova in
Google Scholar
PubMed
Search for other papers by N Pulido in
Google Scholar
PubMed
Search for other papers by AI Suarez in
Google Scholar
PubMed
Search for other papers by E Rodriguez in
Google Scholar
PubMed
Search for other papers by A Rovira in
Google Scholar
PubMed
In 3T3-L1 adipocytes we have examined the effect of tri-iodothyronine (T(3)) on glucose transport, total protein content and subcellular distribution of GLUT1 and GLUT4 glucose transporters. Cells incubated in T(3)-depleted serum were used as controls. Cells treated with T(3) (50 nM) for three days had a 3.6-fold increase in glucose uptake (P<0.05), and also presented a higher insulin sensitivity, without changes in insulin binding. The two glucose carriers, GLUT1 and GLUT4, increased by 87% (P<0.05) and 90% (P<0. 05), respectively, in cells treated with T(3). Under non-insulin-stimulated conditions, plasma membrane fractions obtained from cells exposed to T(3) were enriched with both GLUT1 (3. 29+/-0.69 vs 1.20+/-0.29 arbitrary units (A.U.)/5 microg protein, P<0.05) and GLUT4 (3.50+/-1.16 vs 0.82+/-0.28 A.U./5 microg protein, P<0.03). The incubation of cells with insulin produced the translocation of both glucose transporters to plasma membranes, and again cells treated with T(3) presented a higher amount of GLUT1 and GLUT4 in the plasma membrane fractions (P<0.05 and P<0.03 respectively). These data indicate that T(3) has a direct stimulatory effect on glucose transport in 3T3-L1 adipocytes due to an increase in GLUT1 and GLUT4, and by favouring their partitioning to plasma membranes. The effect of T(3) on glucose uptake induced by insulin can also be explained by the high expression of both glucose transporters.
Search for other papers by Cherish Chong in
Google Scholar
PubMed
Search for other papers by Anis Hamid in
Google Scholar
PubMed
Search for other papers by Tham Yao in
Google Scholar
PubMed
Search for other papers by Amanda E Garza in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Search for other papers by Gail K Adler in
Google Scholar
PubMed
Search for other papers by Jose R Romero in
Google Scholar
PubMed
Search for other papers by Gordon H Williams in
Google Scholar
PubMed
We posit the existence of a paracrine/autocrine negative feedback loop, mediated by the mineralocorticoid receptor (MR), regulating aldosterone secretion. To assess this hypothesis, we asked whether altering MR activity in zona glomerulosa (ZG) cells affects aldosterone production. To this end, we studied ex vivo ZG cells isolated from male Wistar rats fed chow containing either high (1.6% Na+ (HS)) or low (0.03% Na+ (LS)) amount of sodium. Western blot analyses demonstrated that MR was present in both the ZG and zona fasciculata/zona reticularis (ZF/ZR/ZR). In ZG cells isolated from rats on LS chow, MR activation by fludrocortisone produced a 20% and 60% reduction in aldosterone secretion basally and in response to angiotensin II (ANGII) stimulation, respectively. Corticosterone secretion was increased in these cells suggesting that aldosterone synthase activity was being reduced by fludrocortisone. In contrast, canrenoic acid, an MR antagonist, enhanced aldosterone production by up to 30% both basally and in response to ANGII. Similar responses were observed in ZG cells from rats fed HS. Modulating glucocorticoid receptor (GR) activity did not alter aldosterone production by ZG cells; however, altering GR activity did modify corticosterone production from ZF/ZR/ZR cells both basally and in response to adrenocorticotropic hormone (ACTH). Additionally, activating the MR in ZF/ZR/ZR cells strikingly reduced corticosterone secretion. In summary, these data support the hypothesis that negative ultra-short feedback loops regulate adrenal steroidogenesis. In the ZG, aldosterone secretion is regulated by the MR, but not the GR, an effect that appears to be secondary to a change in aldosterone synthase activity.
Faculty of Medicine & Health Sciences, UCSI University, Cheras, Kuala Lumpur, Malaysia
Search for other papers by Yi Jun Desmond Tan in
Google Scholar
PubMed
Search for other papers by Danielle L Brooks in
Google Scholar
PubMed
Faculty of Medicine & Health Sciences, UCSI University, Cheras, Kuala Lumpur, Malaysia
Search for other papers by Kelly Yin Han Wong in
Google Scholar
PubMed
Search for other papers by Yuefei Huang in
Google Scholar
PubMed
Search for other papers by Jose R Romero in
Google Scholar
PubMed
Search for other papers by Jonathan S Williams in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Biologic sex influences the development of cardiovascular disease and modifies aldosterone (ALDO) and blood pressure (BP) phenotypes: females secrete more ALDO, and their adrenal glomerulosa cell is more sensitive to stimulation. Lysine-specific demethylase 1 (LSD1) variants in Africans and LSD1 deficiency in mice are associated with BP and/or ALDO phenotypes. This study, in 18- and 40-week-old wild type (WT) and LSD1+/− mice, was designed to determine whether (1) sex modifies ALDO biosynthetic enzymes; (2) LSD1 deficiency disrupts the effect of sex on these enzymes; (3) within each genotype, there is a positive relationship between ALDO biosynthesis (proximate phenotype), plasma ALDO (intermediate phenotype) and BP levels (distant phenotype); and (4) sex and LSD1 genotype interact on these phenotypes. In WT mice, female sex increases the expression of early enzymes in ALDO biosynthesis but not ALDO levels or systolic blood pressure (SBP). However, enzyme expressions are shifted downward in LSD1+/− females vs males, so that early enzyme levels are similar but the late enzymes are substantially lower. In both age groups, LSD1 deficiency modifies the adrenal enzyme expressions, circulating ALDO levels, and SBP in a sex-specific manner. Finally, significant sex/LSD1 genotype interactions modulate the three phenotypes in mice. In conclusion, biologic sex in mice interacts with LSD1 deficiency to modify several phenotypes: (1) proximal (ALDO biosynthetic enzymes); (2) intermediate (circulating ALDO); and (3) distant (SBP). These results provide entry to better understand the roles of biological sex and LSD1 in (1) hypertension heterogeneity and (2) providing more personalized treatment.
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Damian G Romero in
Google Scholar
PubMed
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Ming Yi Zhou in
Google Scholar
PubMed
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Licy L Yanes in
Google Scholar
PubMed
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Maria W Plonczynski in
Google Scholar
PubMed
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Tanganika R Washington in
Google Scholar
PubMed
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Celso E Gomez-Sanchez in
Google Scholar
PubMed
Department of Medicine, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, USA
DNA Core, University of Missouri-Columbia, Columbia, Missouri 65211, USA
Departments of Physiology and Biophysics and
Pharmacology and Toxicology, The University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
Search for other papers by Elise P Gomez-Sanchez in
Google Scholar
PubMed
Regulators of G-protein signaling (RGS proteins) interact with Gα subunits of heterotrimeric G-proteins, accelerating the rate of GTP hydrolysis and finalizing the intracellular signaling triggered by the G-protein-coupled receptor (GPCR)–ligand interaction. Angiotensin II (Ang II) interacts with its GPCR in adrenal zona glomerulosa cells and triggers a cascade of intracellular signals that regulates steroidogenesis and proliferation. On screening for adrenal zona glomerulosa-specific genes, we found that RGS4 was exclusively localized in the zona glomerulosa of the rat adrenal cortex. We studied RGS4 expression and regulation in the rat adrenal gland, including the signaling pathways involved, as well as the role of RGS4 in steroidogenesis in human adrenocortical H295R cells. We reported that RGS4 mRNA expression in the rat adrenal gland was restricted to the adrenal zonal glomerulosa and upregulated by low-salt diet and Ang II infusion in rat adrenal glands in vivo. In H295R cells, Ang II caused a rapid and transient increase in RGS4 mRNA levels mediated by the calcium/calmodulin/calmodulin-dependent protein kinase and protein kinase C pathways. RGS4 overexpression by retroviral infection in H295R cells decreased Ang II-stimulated aldosterone secretion. In reporter assays, RGS4 decreased Ang II-mediated aldosterone synthase upregulation. In summary, RGS4 is an adrenal gland zona glomerulosa-specific gene that is upregulated by aldosterone secretagogues, in vivo and in vitro, and functions as a negative feedback of Ang II-triggered intracellular signaling. Alterations in RGS4 expression levels or functions may be involved in deregulations of Ang II signaling and abnormal aldosterone secretion.
Search for other papers by Yuefei Huang in
Google Scholar
PubMed
Search for other papers by Pei Yee Ting in
Google Scholar
PubMed
Search for other papers by Tham M Yao in
Google Scholar
PubMed
Search for other papers by Tsuyoshi Homma in
Google Scholar
PubMed
Search for other papers by Danielle Brooks in
Google Scholar
PubMed
Search for other papers by Isis Katayama Rangel in
Google Scholar
PubMed
Search for other papers by Gail K Adler in
Google Scholar
PubMed
Search for other papers by Jose R Romero in
Google Scholar
PubMed
Search for other papers by Jonathan S Williams in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Search for other papers by Gordon H Williams in
Google Scholar
PubMed
Human risk allele carriers of lysine-specific demethylase 1 (LSD1) and LSD1-deficient mice have salt-sensitive hypertension for unclear reasons. We hypothesized that LSD1 deficiency causes dysregulation of aldosterone’s response to salt intake resulting in increased cardiovascular risk factors (blood pressure and microalbumin). Furthermore, we determined the effect of biological sex on these potential abnormalities. To test our hypotheses, LSD1 male and female heterozygote-knockout (LSD1+/−) and WT mice were assigned to two age groups: 18 weeks and 36 weeks. Plasma aldosterone levels and aldosterone production from zona glomerulosa cells studied ex vivo were greater in both male and female LSD1+/− mice consuming a liberal salt diet as compared to WT mice consuming the same diet. However, salt-sensitive blood pressure elevation and increased microalbuminuria were only observed in male LSD1+/− mice. These data suggest that LSD1 interacts with aldosterone’s secretory response to salt intake. Lack of LSD1 causes inappropriate aldosterone production on a liberal salt diet; males appear to be more sensitive to this aldosterone increase as males, but not females, develop salt sensitivity of blood pressure and increased microalbuminuria. The mechanism responsible for the cardiovascular protective effect in females is uncertain but may be related to estrogen modulating the effect of mineralocorticoid receptor activation.
Search for other papers by Amanda E Garza in
Google Scholar
PubMed
Search for other papers by Elijah Trefts in
Google Scholar
PubMed
Search for other papers by Isis A Katayama Rangel in
Google Scholar
PubMed
Search for other papers by Danielle Brooks in
Google Scholar
PubMed
Department of Endocrinology, School of Medicine, Pontificia Universidad Catolica De Chile, Santiago, Chile
Search for other papers by Rene Baudrand in
Google Scholar
PubMed
Search for other papers by Burhanuddin Moize in
Google Scholar
PubMed
Search for other papers by Jose R Romero in
Google Scholar
PubMed
Search for other papers by Sanjay Ranjit in
Google Scholar
PubMed
Search for other papers by Thitinan Treesaranuwattana in
Google Scholar
PubMed
Search for other papers by Tham M Yao in
Google Scholar
PubMed
Search for other papers by Gail K Adler in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Search for other papers by Gordon H Williams in
Google Scholar
PubMed
Aldosterone modulates the activity of both epithelial (specifically renal) and non-epithelial cells. Binding to the mineralocorticoid receptor (MR), activates two pathways: the classical genomic and the rapidly activated non-genomic that is substantially modulated by the level of striatin. We hypothesized that disruption of MR’s non-genomic pathway would alter aldosterone-induced cardiovascular/renal damage. To test this hypothesis, wild type (WT) and striatin heterozygous knockout (Strn+/ −) littermate male mice were fed a liberal sodium (1.6% Na+) diet and randomized to either protocol one: 3 weeks of treatment with either vehicle or aldosterone plus/minus MR antagonists, eplerenone or esaxerenone or protocol two: 2 weeks of treatment with either vehicle or L-NAME/AngII plus/minus MR antagonists, spironolactone or esaxerenone. Compared to the WT mice, basally, the Strn+/ − mice had greater (~26%) estimated renal glomeruli volume and reduced non-genomic second messenger signaling (pAkt/Akt ratio) in kidney tissue. In response to active treatment, the striatin-associated-cardiovascular/renal damage was limited to volume effects induced by aldosterone infusion: significantly increased blood pressure (BP) and albuminuria. In contrast, with aldosterone or L-NAME/AngII treatment, striatin deficiency did not modify aldosterone-mediated damage: in the heart and kidney, macrophage infiltration, and increases in aldosterone-induced biomarkers of injury. All changes were near-normalized following MR blockade with spironolactone or esaxerenone, except increased BP in the L-NAME/AngII model. In conclusion, the loss of striatin amplified aldosterone-induced damage suggesting that aldosterone’s non-genomic pathway is protective but only related to effects likely mediated via epithelial, but not non-epithelial cells.
Search for other papers by Shadi K Gholami in
Google Scholar
PubMed
Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia
Search for other papers by Chee Sin Tay in
Google Scholar
PubMed
Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia
Search for other papers by Jessica M Lee in
Google Scholar
PubMed
Search for other papers by Eleanor Zagoren in
Google Scholar
PubMed
Department of Exercise Science and Athletic Training, Springfield College, Springfield, Massachusetts, USA
Search for other papers by Stephen A Maris in
Google Scholar
PubMed
Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia
Search for other papers by Jian Yao Wong in
Google Scholar
PubMed
Search for other papers by Amanda E Garza in
Google Scholar
PubMed
Search for other papers by Ezgi Caliskan Guzelce in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Search for other papers by Gail K Adler in
Google Scholar
PubMed
Search for other papers by Jose R Romero in
Google Scholar
PubMed
Search for other papers by Gordon H Williams in
Google Scholar
PubMed
Inconsistencies have been reported on the effect of sex on aldosterone (ALDO) levels leading to clinical confusion. The reasons for these inconsistencies are uncertain but include estrogen and/or its receptor modulating target gene responses to mineralocorticoid receptor activation and ALDO secretagogues’ levels. This study’s goal was to determine whether ALDO’s biosynthesis also differed by sex. Two approaches were used. First, plasma renin activity and aldosterone were measured in rats. Both were significantly higher in males. Secondly, using rat zona glomerulosa (ZG) cells, we assessed three ex vivo areas: (1) activity/levels of early steps in ALDO’s biosynthesis (StAR and CYP11A1); (2) activity/levels of a late step (CYP11B2); and (3) the status of the mineralocorticoid receptor (MR)-mediated, ultrashort feedback loop. Females had higher expression of CYP11A1 and StAR and increased CYP11A1 activity (increased pregnenolone/corticosterone levels) but did not differ in CYP11B2 expression or activity (ALDO levels). Activating the ZG’s MR (thereby activating the ultrashort feedback loop) reduced CYP11B2’s activity similarly in both sexes. Exvivo, these molecular effects were accompanied, in females, by lower ALDO basally but higher ALDO with angiotensin II stimulation. In conclusion, we documented that not only was there a sex-mediated difference in the activity of ALDO’s biosynthesis but also these differences at the molecular level help explain the variable reports on ALDO’s circulating levels. Basally, both in vivo and ex vivo, males had higher ALDO levels, likely secondary to higher ALDO secretagogue levels. However, in response to acute stimulation, ALDO levels are higher in females because of the greater levels and/or activity of their StAR/CYP11A1.